eCARTv5 Clinical Deterioration Suite (eCART) vs Microsoft Azure AI (with BAA)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

Microsoft Azure AI (with BAA)

by Microsoft Azure AI

AI Verdict

AgileMD's eCARTv5 is a specialized, FDA-cleared Software as a Medical Device (SaMD) focused on predicting clinical deterioration in hospitalized patients, offering a direct clinical solution. Microsoft Azure AI, conversely, is a broad, HIPAA-compliant platform providing tools and services for developing various AI solutions across healthcare, including clinical decision support, but it is not a pre-built, FDA-cleared application for a specific clinical use case like eCARTv5. Therefore, while both operate in the healthcare AI space and can contribute to clinical decision support, eCARTv5 is a ready-to-deploy product, whereas Azure AI is a foundational platform for building such products.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your primary need is an out-of-the-box, FDA-cleared AI solution specifically designed for continuous, real-time prediction of clinical deterioration in hospitalized adult patients. This tool is ideal for hospitals seeking to implement an early warning system with embedded clinical pathways directly integrated into their EHR, aiming to reduce ICU transfers and mortality with minimal false alarms.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose Microsoft Azure AI (with BAA) if…

Choose Microsoft Azure AI if you are a healthcare organization looking to build and deploy custom, scalable AI solutions across various use cases, from clinical decision support to research, with robust HIPAA and BAA compliance. This platform is best suited for those with in-house development capabilities or partners, who require a flexible, comprehensive suite of AI services (like Azure OpenAI Service, Machine Learning, and Cognitive Services) to create tailored AI applications and conversational healthcare experiences.

View Microsoft Azure AI (with BAA) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Microsoft Azure AI (with BAA)
Pricing	Contact vendor for tailored quote.	Varied, with pay-as-you-go and commitment pricing options.
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud, Edge, Hybrid. Options include Azure Machine Learning Managed Endpoints, Azure Kubernetes Service (AKS), Azure Functions, Azure App Service, Azure IoT Edge, Azure Batch, and Custom Deployment with Virtual Machines (VMs).
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Not applicable AI-estimated
HIPAA	Unknown	Yes AI-estimated
EHR Integration	Not specified	Epic

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCART is praised by users for its intuitive interface, seamless integration with EHRs, and customizable alerts, which streamline workflows and reduce clinician workload. Microsoft Azure AI, while offering powerful tools, requires significant development and customization by the user, making it less of an out-of-the-box solution for direct clinical end-users.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 is an FDA-cleared SaMD specifically designed for continuous patient risk assessment and prediction of clinical deterioration, with extensive clinical validation demonstrating high accuracy across diverse patient populations. Microsoft Azure AI provides a platform for developing AI solutions, but its direct clinical value is dependent on the specific solutions built upon it, and while it offers tools for clinical decision support, it is not a pre-built, FDA-cleared clinical tool like eCARTv5.

Pricing & Value

Microsoft Azure AI (with BAA)

Microsoft Azure AI offers varied pricing with pay-as-you-go and commitment options, along with a free trial, providing transparency and flexibility for different organizational sizes and needs. AgileMD's eCART requires contacting the vendor for a tailored quote, with pricing details not publicly listed, which offers less upfront transparency.

Enterprise Readiness

Microsoft Azure AI (with BAA)

Microsoft Azure AI is a comprehensive cloud platform with extensive deployment options (Cloud, Edge, Hybrid), broad language support, and a vast customer base, indicating robust enterprise readiness for organizations of all sizes. AgileMD's eCART is cloud-based and integrates with EHRs, but as a specialized solution, its enterprise readiness is focused on its specific use case rather than a broad platform offering.

Innovation

Tie

AgileMD's eCARTv5 demonstrates innovation through its FDA-cleared, AI-powered predictive analytics for clinical deterioration, leveraging a gradient-boosted machine learning model and real-time EHR data. Microsoft Azure AI offers a broad range of innovative AI services, including Azure OpenAI Service and advanced machine learning capabilities, enabling the development of cutting-edge healthcare AI solutions. Both tools represent significant innovation in their respective domains within healthcare AI.

Support & Docs

Microsoft Azure AI (with BAA)

Microsoft Azure AI, as a major platform provider, offers extensive documentation, training modules, and a broad support ecosystem for its numerous services and developer tools. AgileMD, while providing a specialized and integrated solution, does not publicly detail its support and documentation offerings to the same extent as a large platform like Azure AI.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Microsoft Azure AI (with BAA)
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	Microsoft Azure AI (with BAA)
Company	AgileMD	Microsoft Azure AI
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	A secure, HIPAA-compliant platform with BAA support for developing and deploying AI solutions across the healthcare industry, from clinical decision support to research.
Key Features	AI-powered clinical deterioration prediction; Continuous patient risk assessment (death or ICU transfer); EHR integration with real-time data (up to 97 variables); Embedded clinical pathways for care guidance; Early warning system (alerts hours before critical illness); Risk stratification (eCART score and risk designation); Minimizes false alarms and clinician workload; Reporting and benchmarking capabilities.	HIPAA and BAA compliance; Azure OpenAI Service; Azure Machine Learning; Azure Cognitive Services (Speech, Vision, Language); Healthcare APIs; Data security and privacy; Scalable infrastructure; Integration with EHRs (e.g., Epic).
Free Trial	Not specified	1

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Microsoft Azure AI (with BAA).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool integrate into existing EHR workflows and what is the depth of that integration?

eCARTv5 is designed for direct integration into EHR systems, continuously analyzing up to 97 real-time variables from patient data like labs, vital signs, and nursing assessments to provide an eCART score and risk designation. This integration embeds clinical pathways directly into the workflow to guide care. Microsoft Azure AI offers a platform for developing and deploying AI solutions that can integrate with EHRs, such as Epic, to streamline administrative processes, provide AI-powered clinical insights, and automate tasks like note summarization and coding suggestions.

What is the accuracy and sensitivity of each tool in its respective clinical application?

eCARTv5 has demonstrated high accuracy in predicting clinical deterioration (death or ICU transfer) with an AUROC of 0.834 in retrospective validation, outperforming other early warning scores. Its performance remained high across diverse patient demographics and clinical conditions during prospective validation. Microsoft Azure AI provides a platform for building AI solutions, and the accuracy and sensitivity would depend on the specific AI models developed and deployed on the platform for particular clinical applications.

What is the typical learning curve for physicians and clinical staff using these tools?

eCARTv5 is designed to integrate into the EHR workflow and provides standardized guidance through embedded clinical pathways, which may suggest a more guided user experience. For Microsoft Azure AI, the learning curve would vary significantly based on the specific AI solution implemented; however, Microsoft aims to streamline workflows and reduce administrative burdens, which could imply a focus on user-friendly interfaces for end-users.

What kind of customer support and resources are available for implementation and ongoing use?

While specific details on support quality are not provided for eCARTv5, its integration with EHRs and embedded clinical pathways suggest a structured approach to implementation. Microsoft Azure AI, as a comprehensive platform, offers extensive resources for development and deployment, and its focus on empowering healthcare organizations implies robust support for building and scaling AI solutions.

Can these tools be effectively rolled out across multiple hospital sites with varying EHR configurations?

eCARTv5 has been validated across 21 hospitals from three health systems, indicating its capability for multi-site deployment and consistent accuracy across diverse patient demographics and medical conditions. Microsoft Azure AI is built for scalability and offers flexible deployment options (cloud, edge, hybrid), making it suitable for organizations of all sizes and potentially adaptable to varying EHR configurations across multiple sites.

Are there customer references or case studies available to demonstrate real-world impact and time-to-value?

eCARTv5 has been validated through extensive clinical performance data from nearly two million hospitalizations across 21 hospitals, and its development is grounded in over a decade of research at the University of Chicago. Microsoft Azure AI highlights how organizations are using AI to improve operational efficiency, clinician well-being, and patient experiences, with examples of customers using Azure AI services to automate tasks and reduce administrative burden.